Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)
A higher TMB in PWH may portend a more favorable response to certain cancer treatment modalities such as immune checkpoint inhibitors.
Authors
- Gregory Riedlinger (ORCID: https://orcid.org/0000-0001-5690-7777)
- Anna E. Coghill (ORCID: https://orcid.org/0000-0001-7142-7499)
- Bryan P. Schneider (ORCID: https://orcid.org/0000-0003-1868-7739)
- Robert A. Baiocchi (ORCID: https://orcid.org/0000-0002-1619-4853)
- Nathan Van Bibber
- Gita Suneja (ORCID: https://orcid.org/0000-0002-5933-211X)
- Daniel Abate‐Daga (ORCID: https://orcid.org/0000-0002-2571-0215)
- Susanne M. Arnold (ORCID: https://orcid.org/0000-0001-6542-9551)
- Jamie K. Teer (ORCID: https://orcid.org/0000-0003-4513-0282)
- Miguel Gomez Fontela (ORCID: https://orcid.org/0000-0002-7563-3350)
- Yonghong Zhang (ORCID: https://orcid.org/0000-0001-9565-7563)
Institutions
- Rutgers, The State University of New Jersey (US)
- Indiana University Health (US)
- University of Kentucky (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
- Markey Cancer Center (US)
- Moffitt Cancer Center (US)
- Indiana Cancer Consortium (US)
- Indiana University Bloomington (US)
- Duke University Health System (US)
- Rutgers Cancer Institute (US)
- The Ohio State University (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1321
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05